Grant: Canada Research Chairs
University of Guelph
$120,000.00
Antimicrobial Resistance
EF 2024-25
Résumé
Overview. Antimicrobial resistance (AMR) seriously challenges the clinical efficacy of life-saving antibiotics, with devastating implications for world health. Innovation is urgently needed, including the development of new therapeutics to combat antibiotic-resistant bacteria. This research program will apply leading-edge approaches to study the genetic and molecular underpinnings of bacterial drug efflux pumps—major multi-drug resistance elements—in addition to exploring the mechanisms used by bacteria to enhance virulence.
Aim 1. Exploring and overcoming Escherichia coli drug efflux pumps. E. coli was estimated to be the leading cause of global deaths associated with resistance and drug efflux pumps are major contributors to antibiotic resistance in this bacterial pathogen. Harnessing unique genetic and chemical resources, the contribution of efflux pumps to E. coli fitness and drug resistance will be explored. Overall, this study will provide comprehensive insight into the resistance potential of the E. coli efflux network, identifying host-associated cues impacting efflux gene expression, the substrate properties governing efflux, and the ancestral functions of these ancient transporters. In a broader context, this study may facilitate the development of approaches to overcome AMR.
Aim 2. Investigating and inhibiting Staphylococcus aureus host adhesion. An attractive alternative approach to overcome AMR is to target the virulence factors bacteria harness to colonize and infect the host. S. aureus was the second leading global cause of death associated with resistance. Genetic, biochemical, and advanced imaging techniques will be used to gain insight into the molecular underpinnings of S. aureus host adhesion. This information will inform approaches to inhibit S. aureus host adhesion, including the functional characterization of newly identified anti-adhesive compounds. Overall, this study will advance our fundamental understanding of the S. aureus host interaction, which is essential for the development of strategies to inhibit virulence.
Significance. This research represents unconventional approaches to the discovery of new antimicrobial therapies, while also providing insight into important bacterial physiological processes. This innovative research program will help position Canada at the forefront of leading-edge AMR research and will increase our global reputation in this area.
Programme
Canada Research Chairs
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
CRC-2022-00301
Name nom
Cox, Georgina
Department département
Molecular and Cellular Biology - University of Guelph
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2022
Award amount
120000
Program id
CRC
Program name en
Canada Research Chairs
Program name fr
Chaires de recherche du Canada
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
9998
Committee name en
Canada Research Chair Selection Committee
Committee name fr
Comité de sélection des Chaires de recherche du Canada
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Field of research list codes
RDF1060601
Field of research list names en
Anthropological genetics
Field of research list names fr
Génétique anthropologique
Socioeconomic objective list codes
RDS10799
Socioeconomic objective list names en
Health, n.e.c.
Socioeconomic objective list names fr
Santé, n.c.a.
Application title
Antimicrobial Resistance
Keywords
Antimicrobial resistance; Efflux; Virulence; Escherichia coli; Staphylococcus aureus
Application summary
Overview. Antimicrobial resistance (AMR) seriously challenges the clinical efficacy of life-saving antibiotics, with devastating implications for world health. Innovation is urgently needed, including the development of new therapeutics to combat antibiotic-resistant bacteria. This research program will apply leading-edge approaches to study the genetic and molecular underpinnings of bacterial drug efflux pumps—major multi-drug resistance elements—in addition to exploring the mechanisms used by bacteria to enhance virulence.
Aim 1. Exploring and overcoming Escherichia coli drug efflux pumps. E. coli was estimated to be the leading cause of global deaths associated with resistance and drug efflux pumps are major contributors to antibiotic resistance in this bacterial pathogen. Harnessing unique genetic and chemical resources, the contribution of efflux pumps to E. coli fitness and drug resistance will be explored. Overall, this study will provide comprehensive insight into the resistance potential of the E. coli efflux network, identifying host-associated cues impacting efflux gene expression, the substrate properties governing efflux, and the ancestral functions of these ancient transporters. In a broader context, this study may facilitate the development of approaches to overcome AMR.
Aim 2. Investigating and inhibiting Staphylococcus aureus host adhesion. An attractive alternative approach to overcome AMR is to target the virulence factors bacteria harness to colonize and infect the host. S. aureus was the second leading global cause of death associated with resistance. Genetic, biochemical, and advanced imaging techniques will be used to gain insight into the molecular underpinnings of S. aureus host adhesion. This information will inform approaches to inhibit S. aureus host adhesion, including the functional characterization of newly identified anti-adhesive compounds. Overall, this study will advance our fundamental understanding of the S. aureus host interaction, which is essential for the development of strategies to inhibit virulence.
Significance. This research represents unconventional approaches to the discovery of new antimicrobial therapies, while also providing insight into important bacterial physiological processes. This innovative research program will help position Canada at the forefront of leading-edge AMR research and will increase our global reputation in this area.